IP Verse

Therapeutic Compositions For Treatment Of Human Immunodeficiency Virus

Patent No. EP3346995 (titled "Therapeutic Compositions For Treatment Of Human Immunodeficiency Virus") was filed by Gilead Sciences on Nov 8, 2016. The application was issued on Aug 28, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
COOKEMay 28, 2020ELKINGTON AND FIFE
SANDOZMay 28, 2020TER MEER STEINMEISTER & PARTNER
TEVA PHARMACEUTICALSMay 27, 2020KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3346995

GILEAD SCIENCES
Application Number
EP16798063A
Filing Date
Nov 8, 2016
Status
Granted And Under Opposition
Jul 26, 2019
Publication Date
Aug 28, 2019
External Links
Slate, Register , Google Patents